![]() CellFE CellFE is a company that develops a microfluidic device designed to deliver gene-editing molecules into the human cells. | ![]() Senti Biosciences Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies. | ![]() Avrobio Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. | |
Founding Date | Founding Date 2018 | Founding Date 2016 | Founding Date N/A |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Alameda, US HQ | Locations South San Francisco, US HQ | Locations Cambridge, US HQ |
Employees | Employees 287% decrease | Employees 916% decrease | Employees 8573% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 m | Valuation ($) 5.2 m |
Financial | |||
Net income | Net income N/A | Net income ($61.4m) (FY, 2025) | Net income ($74.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 4.8m | Total funding raised $ 53m | Total funding raised $ 85m |

Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
View company
Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
View company